Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10421744 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent 10421744 was granted and assigned to Pfizer Limited on September, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10421744

Patent Inventor Names

Bruce Nelsen Rogers0

Michael Eric Green0

Scot Richard Mente0

Steven Victor O'Neil0

Amy Beth Dounay0

Chewah Lee0

David Lawrence Firman Gray0

Ivan Viktorovich Efremov0

...

Date of Patent

September 24, 2019

Patent Application Number

16123072

Date Filed

September 6, 2018

Patent Citations

‌

US Patent 10093655 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent Citations Received

‌

US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands

‌

US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention provides, in part, compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10421744 Heteroaromatic compounds and their use as dopamine D1 ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API